A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function




TekijätAndrabi SBA, Batkulwar K, Bhosale SD, Moulder R, Khan MH, Buchacher T, Khan MM, Arnkil I, Rasool O, Marson A, Kalim UU, Lahesmaa R

Julkaisuvuosi2023

JournalImmunology Letters

Tietokannassa oleva lehden nimiImmunology letters

Lehden akronyymiImmunol Lett

Vuosikerta263

Aloitussivu123

Lopetussivu132

ISSN0165-2478

eISSN1879-0542

DOIhttps://doi.org/10.1016/j.imlet.2023.09.001

Verkko-osoitehttps://doi.org/10.1016/j.imlet.2023.09.001

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/181811045


Tiivistelmä
Transcriptional repressor, hypermethylated in cancer 1 (HIC1) participates in a range of important biological processes, such as tumor repression, immune suppression, embryonic development and epigenetic gene regulation. Further to these, we previously demonstrated that HIC1 provides a significant contribution to the function and development of regulatory T (Treg) cells. However, the mechanism by which it regulates these processes was not apparent. To address this question, we used affinity-purification mass spectrometry to characterize the HIC1 interactome in human Treg cells. Altogether 61 high-confidence interactors were identified, including IKZF3, which is a key transcription factor in the development of Treg cells. The biological processes associated with these interacting proteins include protein transport, mRNA processing, non-coding (ncRNA) transcription and RNA metabolism. The results revealed that HIC1 is part of a FOXP3-RUNX1-CBFB protein complex that regulates Treg signature genes thus improving our understanding of HIC1 function during early Treg cell differentiation.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-27-03 at 22:00